Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1. ...

In 2024, Abbott Laboratories ABT faced industry-wide challenges that ... growth strategy have helped it maintain an uptrend in its stock performance. With new product launches and strategic ...

ABT currently has a PEG ratio of 2.43. Another notable valuation metric for HAE is its P/B ratio of 4.28. Investors use the P/B ratio to look at a stock's market value versus its book value ...

ABBOTT LABORATORIES (ABT) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 91% based on the firm’s underlying fundamentals and the ...

ABBOTT LABORATORIES (ABT) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 62% based on the firm’s underlying fundamentals and the ...